Select Medical Is Maintained at Outperform by RBC Capital
Select Medical Hldgs Analyst Ratings
Benchmark Co. Upgrades Select Medical Holdings(SEM.US) to Buy Rating, Announces Target Price $23
RBC Capital Maintains Select Medical Holdings(SEM.US) With Buy Rating, Cuts Target Price to $23
Deutsche Bank Adjusts Select Medical Price Target to $25 From $26, Maintains Buy Rating
BofA Securities Maintains Select Medical Holdings(SEM.US) With Buy Rating, Announces Target Price $24
Select Medical Is Maintained at Neutral by UBS
UBS Maintains Neutral on Select Medical Hldgs, Lowers Price Target to $21
Select Medical Hldgs Analyst Ratings
BofA Securities Maintains Select Medical Holdings(SEM.US) With Buy Rating
BofA Securities Maintains Select Medical Holdings(SEM.US) With Buy Rating, Announces Target Price $24
Select Medical Hldgs Analyst Ratings
Benchmark Co. Downgrades Select Medical Holdings(SEM.US) to Hold Rating
Select Medical Is Maintained at Outperform by RBC Capital
Select Medical Hldgs Analyst Ratings
RBC Capital Maintains Select Medical Holdings(SEM.US) With Buy Rating, Raises Target Price to $47
Benchmark Co. Maintains Select Medical Holdings(SEM.US) With Buy Rating, Maintains Target Price $48
Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target
Select Medical Price Target Maintained With a $48.00/Share by Benchmark
Select Medical Hldgs Analyst Ratings